![Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice](https://bjgp.org/content/bjgp/71/706/e364/F1.large.jpg)
Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice
![The utility of PSA density and free PSA in the prostate biopsy decision pathway in a South African population | African Urology The utility of PSA density and free PSA in the prostate biopsy decision pathway in a South African population | African Urology](https://journals.co.za/cms/asset/4711f809-80b1-4b22-a1e6-97635ba13529/mp.afurol.v2.n2.cover.jpg)
The utility of PSA density and free PSA in the prostate biopsy decision pathway in a South African population | African Urology
![Does a Delayed Cull Phenomenon Explain the Discrepancy in PSA Scores Among African American and European American Men | Semantic Scholar Does a Delayed Cull Phenomenon Explain the Discrepancy in PSA Scores Among African American and European American Men | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d89b4ed0b2f72bec677ce0748e3dc16d2e1776d4/14-Table1-1.png)
Does a Delayed Cull Phenomenon Explain the Discrepancy in PSA Scores Among African American and European American Men | Semantic Scholar
![Esame del PSA: l'Antigene Prostatico specifico, a cosa serve e quando farlo. - Multimed Network Sanitario Esame del PSA: l'Antigene Prostatico specifico, a cosa serve e quando farlo. - Multimed Network Sanitario](https://www.multimed.it/images/blog/22565488_shutterstock_243405238-min.jpg)
Esame del PSA: l'Antigene Prostatico specifico, a cosa serve e quando farlo. - Multimed Network Sanitario
![Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0731708521005811-ga1.jpg)
Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect
![PSA response to antiandrogen withdrawal: a systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases PSA response to antiandrogen withdrawal: a systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41391-021-00337-0/MediaObjects/41391_2021_337_Fig2_HTML.png)
PSA response to antiandrogen withdrawal: a systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases
![Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy - Hartrampf - 2022 - The Prostate - Wiley Online Library Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy - Hartrampf - 2022 - The Prostate - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c5def381-c67b-46da-881e-29654ef69718/pros24414-fig-0003-m.jpg)
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy - Hartrampf - 2022 - The Prostate - Wiley Online Library
![Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.350.issue-22/nejmoa031918/production/images/img_medium/nejmoa031918_t2.jpeg)
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM
![Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy](https://www.frontiersin.org/files/Articles/656444/fonc-11-656444-HTML/image_m/fonc-11-656444-t001.jpg)
Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
![Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy](https://www.frontiersin.org/files/Articles/656444/fonc-11-656444-HTML/image_m/fonc-11-656444-t002.jpg)
Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
UroToday.com on Twitter: "PSA Outcomes in Black and White chemotherapy-naïve #ProstateCancer patients treated with enzalutamide. Presentation by @CaPsurvivorship @DanaFarber. #GU22 written coverage by @zklaassen_md @GACancerCenter on UroToday > ...
![NEAUA - Men with Hereditary Prostate Cancer Have Improved Outcomes after Radical Prostatectomy in the PSA Era</b> NEAUA - Men with Hereditary Prostate Cancer Have Improved Outcomes after Radical Prostatectomy in the PSA Era</b>](https://meeting.neaua.org/abstracts/2011/images/g194_1.jpg)
NEAUA - Men with Hereditary Prostate Cancer Have Improved Outcomes after Radical Prostatectomy in the PSA Era</b>
![ASCO GU 2022: Survival Outcomes and Characterization of Patients With Metastatic Castration-Sensitive Prostate Cancer Undergoing Intensified ADT Who Do Not Achieve an Optimal PSA Response (PSA ≤0.2 Ng/ML) ASCO GU 2022: Survival Outcomes and Characterization of Patients With Metastatic Castration-Sensitive Prostate Cancer Undergoing Intensified ADT Who Do Not Achieve an Optimal PSA Response (PSA ≤0.2 Ng/ML)](https://www.urotoday.com/images/com-doc-importer/49-asco-gu-2022/asco-gu-2022-survival-outcomes-and-characterization-of-patients-pts-with-metastatic-castration-sensitive-prostate-cancer-mcspc-undergoing-intensified-androgen-deprivation-therapy-adt-who-do-not-achieve-an-optimal-psa-response-psa-0-2-ng-ml/image-1.jpg)
ASCO GU 2022: Survival Outcomes and Characterization of Patients With Metastatic Castration-Sensitive Prostate Cancer Undergoing Intensified ADT Who Do Not Achieve an Optimal PSA Response (PSA ≤0.2 Ng/ML)
![Cancers | Free Full-Text | Early PSA Change after [177Lu]PSMA-617 Radioligand Therapy as a Predicator of Biochemical Response and Overall Survival Cancers | Free Full-Text | Early PSA Change after [177Lu]PSMA-617 Radioligand Therapy as a Predicator of Biochemical Response and Overall Survival](https://www.mdpi.com/cancers/cancers-14-00149/article_deploy/html/images/cancers-14-00149-g004.png)
Cancers | Free Full-Text | Early PSA Change after [177Lu]PSMA-617 Radioligand Therapy as a Predicator of Biochemical Response and Overall Survival
![Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen | Journal of Urology Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen | Journal of Urology](https://www.auajournals.org/cms/asset/e8aac3c7-8046-43a3-8859-06c809e09b13/abs-fig.jpg)
Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen | Journal of Urology
![Cancers | Free Full-Text | Early PSA Change after [177Lu]PSMA-617 Radioligand Therapy as a Predicator of Biochemical Response and Overall Survival Cancers | Free Full-Text | Early PSA Change after [177Lu]PSMA-617 Radioligand Therapy as a Predicator of Biochemical Response and Overall Survival](https://pub.mdpi-res.com/cancers/cancers-14-00149/article_deploy/html/images/cancers-14-00149-ag-550.jpg?1640771400)
Cancers | Free Full-Text | Early PSA Change after [177Lu]PSMA-617 Radioligand Therapy as a Predicator of Biochemical Response and Overall Survival
![Table 6.2 from Prostate Specific Antigen (PSA) growth curves: A method to improve prostate cancer screening | Semantic Scholar Table 6.2 from Prostate Specific Antigen (PSA) growth curves: A method to improve prostate cancer screening | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f25d05a5e06f122591c498c5f9971db0b7856847/146-Table6.2-1.png)